Literature DB >> 18951422

Self-expandable metal stents and trans-stent light delivery: are metal stents and photodynamic therapy compatible?

Luo-Wei Wang1, Li-Bo Li, Zhao-Shen Li, Yang K Chen, Fred W Hetzel, Zheng Huang.   

Abstract

BACKGROUND AND OBJECTIVES: Obstructive non-small cell lung cancer and obstructive esophageal cancer are US FDA approved indications of photodynamic therapy (PDT). The usefulness of PDT for the treatment of cholangiocarcinoma is currently under clinical investigation. Endoscopic stenting for lumen restoration is a common palliative intervention for those indications. It is important to assess whether self-expandable metal stents are compatible with trans-stent PDT light delivery. STUDY DESIGN/
MATERIALS AND METHODS: Direct effects of various components of metal biliary (n = 2), esophageal (n = 2), and bronchial (n = 1) stents on PDT light transmittance and distribution were examined using a point or linear light source (630 or 652 nm diode laser). Resected pig biliary duct and esophageal wall tissues were used to examine the feasibility of PDT light delivery through the fully expanded metal stents.
RESULTS: While using a point light source, the metal components (thread and joint) of the stent could cause a significant shadow effect. The liner material (polytetrafluoroethylene or polyurethane) could cause various degrees of light absorption. When the stent was covered with a thin layer of biliary duct and esophageal tissues containing all wall layers, the shadow effect could be mitigated due to tissue scattering.
CONCLUSIONS: This study clearly demonstrates that it is feasible to combine stenting and PDT for the treatment of luminal lesions. PDT light dose should be adjusted to counteract the reduction of light transmittance caused by the metal and liner materials of stent. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18951422      PMCID: PMC2593621          DOI: 10.1002/lsm.20680

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  27 in total

1.  Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma.

Authors:  Franz Ludwig Dumoulin; Thomas Gerhardt; Sybille Fuchs; Christian Scheurlen; Michael Neubrand; Günter Layer; Tilman Sauerbruch
Journal:  Gastrointest Endosc       Date:  2003-06       Impact factor: 9.427

2.  Photodynamic therapy for the treatment of tumor ingrowth in expandable esophageal stents.

Authors:  D M Scheider; M Siemens; M Cirocco; G B Haber; G Kandel; P Kortan; N E Marcon
Journal:  Endoscopy       Date:  1997-05       Impact factor: 10.093

3.  Optimization of light dosimetry for photodynamic therapy of Barrett's esophagus: efficacy vs. incidence of stricture after treatment.

Authors:  Masoud Panjehpour; Bergein F Overholt; Mary N Phan; John M Haydek
Journal:  Gastrointest Endosc       Date:  2005-01       Impact factor: 9.427

4.  Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.

Authors:  Helmut Witzigmann; Frieder Berr; Ulrike Ringel; Karel Caca; Dirk Uhlmann; Konrad Schoppmeyer; Andrea Tannapfel; Christian Wittekind; Joachim Mossner; Johann Hauss; Marcus Wiedmann
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

5.  Self-expandable metal stent placement for the palliation of malignant gastroduodenal obstruction: experience in a large, single, UK centre.

Authors:  A S Lowe; C G Beckett; S Jowett; J May; S Stephenson; A Scally; E Tam; C L Kay
Journal:  Clin Radiol       Date:  2007-05-24       Impact factor: 2.350

6.  Photodynamic therapy for the treatment of tumor ingrowth in expandable esophageal stents.

Authors:  M Conio; C J Gostout
Journal:  Gastrointest Endosc       Date:  1998-08       Impact factor: 9.427

7.  Lasers and light sources for PDT: past, present and future.

Authors:  Thomas S Mang
Journal:  Photodiagnosis Photodyn Ther       Date:  2004-05       Impact factor: 3.631

8.  Palliation of Dysphagia of Esophageal Cancer by Endoscopic Lumen Restoration Techniques.

Authors: 
Journal:  Cancer Control       Date:  1999-01       Impact factor: 3.302

9.  Outcomes of tracheobronchial stents in patients with malignant airway disease.

Authors:  Anthony Lemaire; William R Burfeind; Eric Toloza; Scott Balderson; Rebecca P Petersen; David H Harpole; Thomas A D'Amico
Journal:  Ann Thorac Surg       Date:  2005-08       Impact factor: 4.330

Review 10.  Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer?

Authors:  K Moghissi; K Dixon
Journal:  Eur Respir J       Date:  2003-09       Impact factor: 16.671

View more
  4 in total

Review 1.  Photodynamic therapy for unresectable cholangiocarcinoma.

Authors:  Yutaka Tomizawa; Jianmin Tian
Journal:  Dig Dis Sci       Date:  2011-11-06       Impact factor: 3.199

Review 2.  Advances in endoscopic retrograde cholangiopancreatography for the treatment of cholangiocarcinoma.

Authors:  Dushant S Uppal; Andrew Y Wang
Journal:  World J Gastrointest Endosc       Date:  2015-06-25

Review 3.  Palliation: Hilar cholangiocarcinoma.

Authors:  Mahesh Kr Goenka; Usha Goenka
Journal:  World J Hepatol       Date:  2014-08-27

4.  Advance in photosensitizers and light delivery for photodynamic therapy.

Authors:  Il Yoon; Jia Zhu Li; Young Key Shim
Journal:  Clin Endosc       Date:  2013-01-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.